CC-92480-MM-001: A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and Refractory Multiple Myeloma
Principal investigator: Pekka Anttila
HUS Helsinki University Hospital, Comprehensive Cancer Center